The "Rani stock forecast" aligns with sector optimism, as peer companies also see valuation uplifts on clinical trial breakthroughs. Analysts recommend monitoring trade volume spikes as signals for possible price accelerations. Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent. More information about Rani Therapeutics can be found on their website at ranitherapeutics.com. According to recent market data, "Rani stock forecast" models project a 7–12% upside in the near term, backed by robust institutional accumulation. Technical charts show support around $7.80, with resistance forming at $9.35, suggesting a possible breakout if positive earnings materialize.